Marty Makary has announced his resignation from the role of Commissioner at the Food and Drug Administration, marking the end of a tumultuous period for the agency.
His departure comes as the FDA faces various challenges, prompting the appointment of Diamantas, the agency’s top food official, to step in as interim commissioner.
The transition in leadership raises questions about the future direction of the FDA during a time of scrutiny and evolving public health needs.